HealthAlleyWatch6 days ago
Precision Neuroscience Secures $250M in Series D Funding
1 min read
Precision Neuroscience, a medical device company developing brain-computer interfaces for paralysis, successfully raised $250 million in a Series D funding round. This capital injection, led by Pershing Square Inc., supports the company's mission to restore communication and movement for patients affected by neurological disease.
Level
Hype check
Tap to vote and see what everyone thinks.
